MedPath

Tabriz University of Medical Sciences trial of inpatient intravenous urographin plus corticosteroid versus outpatient oral corticosteroid therapy in the Sudden Sensorineural Hearing Loss

Not Applicable
Completed
Conditions
Sudden Sensorineural Hearing Loss
Ear, Nose and Throat
Sensorineural hearing loss
Registration Number
ISRCTN84083523
Lead Sponsor
Tabriz University of Medical Sciences (TUMS) (Iran)
Brief Summary

2008 Results article in https://pubmed.ncbi.nlm.nih.gov/18819635/ (added 02/09/2021)

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
All
Target Recruitment
51
Inclusion Criteria

1. Aged over 12 years
2. A greater than 20 dB hearing loss over at least three frequencies on audiometric testing

Exclusion Criteria

1. General medical condition necessitating a specific therapy
2. Incompliance to the medications

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Hearing recovery as shown by pure tone average on audiogram.
Secondary Outcome Measures
NameTimeMethod
o secondary outcome measures
© Copyright 2025. All Rights Reserved by MedPath